We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
-10.91%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$3.8B
AUM Growth
-$501M
Cap. Flow
-$427M
Cap. Flow %
-11.23%
Top 10 Hldgs %
9.48%
Holding
2,955
New
715
Increased
515
Reduced
468
Closed
751

Sector Composition

Rank Sector Weight
1 Financials 16.01%
2 Healthcare 9.13%
3 Technology 8.13%
4 Consumer Discretionary 6.63%
5 Industrials 4.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTRPA
2101
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$33K ﹤0.01%
43,610
-131,153
-75% -$169K
IDEX
2102
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$33K ﹤0.01%
+396
New +$35.7K
SPPI
2103
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$33K ﹤0.01%
+42,111
New +$37.1K
HGEN
2104
DELISTED
HUMANIGEN, INC.
HGEN
$33K ﹤0.01%
+18,660
New +$41.9K
EOSE icon
2105
Eos Energy Enterprises
EOSE
$1.41B
$32K ﹤0.01%
+26,224
New +$53.8K
IVDAW icon
2106
Iveda Solutions Warrant
IVDAW
$51.3K
$32K ﹤0.01%
+24,000
New +$10.9K
KOPN icon
2107
Kopin
KOPN
$749M
$32K ﹤0.01%
28,233
+14,898
+112% +$22.4K
NCMI icon
2108
National CineMedia
NCMI
$385M
$32K ﹤0.01%
+3,505
New +$59.3K
OMER icon
2109
Omeros
OMER
$919M
$32K ﹤0.01%
+11,793
New +$40K
QMCO icon
2110
Quantum Corp
QMCO
$456M
$32K ﹤0.01%
1,130
-5,281
-82% -$200K
VRCA icon
2111
Verrica Pharmaceuticals
VRCA
$96.4M
$32K ﹤0.01%
+1,667
New +$83.8K
RUBY
2112
DELISTED
Rubius Therapeutics, Inc
RUBY
$32K ﹤0.01%
+37,500
New +$62.9K
ZY
2113
DELISTED
Zymergen Inc. Common Stock
ZY
$32K ﹤0.01%
+26,042
New +$43.7K
CUE icon
2114
Cue Biopharma
CUE
$115M
$31K ﹤0.01%
+412
New +$48.2K
RTB
2115
RTB Digital
RTB
$232M
$31K ﹤0.01%
+84
New +$80.9K
AMTI
2116
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$31K ﹤0.01%
+10,745
New +$45.1K
OUST icon
2117
Ouster
OUST
$3.08B
$30K ﹤0.01%
+1,838
New +$51.5K
VATE icon
2118
INNOVATE Corp
VATE
$102M
$30K ﹤0.01%
+1,708
New +$46.8K
QVCGA
2119
DELISTED
QVC Group Inc Series A
QVCGA
$30K ﹤0.01%
206
-207
-50% -$40.2K
VAPO
2120
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$29K ﹤0.01%
+1,438
New +$52.6K
SFT
2121
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$29K ﹤0.01%
+4,263
New +$52.4K
LGHLW
2122
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$28K ﹤0.01%
32,895
PGEN icon
2123
Precigen
PGEN
$2.5B
$28K ﹤0.01%
20,712
+3,666
+22% +$5.44K
SOBR icon
2124
SOBR Safe
SOBR
$1.55M
$28K ﹤0.01%
+26
New +$30.1K
MNTSW icon
2125
Momentus Inc Warrant
MNTSW
$41
$27K ﹤0.01%
12,597

Similar funds

Boothbay Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Boothbay Fund Management held 2,955 positions worth $3.8B, down 12% from $4.3B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Boothbay Fund Management withdrew a net $427M in Q2 2022, closing 751 positions and reducing 468 holdings. Its most notable exit was iShares MBS ETF, an estimated $33.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boothbay Fund Management opened a new position in Restaurant Brands International worth $11.5M.

  • Boothbay Fund Management's largest Q2 2022 buy was Restaurant Brands International: 228,887 shares worth $11.5M.
  • Boothbay Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $49.1M increase.
  • Boothbay Fund Management's biggest Q2 2022 reduction was Sprott Physical Gold and Silver Trust, cutting an estimated $14.2M.
  • Boothbay Fund Management fully exited iShares MBS ETF in Q2 2022, selling an estimated $33.5M.
  • Boothbay Fund Management's ten largest holdings make up 9.5% of its $3.8B portfolio in Q2 2022.
  • Boothbay Fund Management opened 715 new positions and closed 751 in Q2 2022.
  • Boothbay Fund Management's portfolio value fell 12% quarter-over-quarter to $3.8B.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.